Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-03

FDA Approved: BACLOFEN — Supplemental Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approves a supplemental application for Baclofen from Advagen Pharma Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

SUPPL AP for BACLOFEN (BACLOFEN)